Insulinoma induces a hyperinsulinemia-mediated decrease of GLUT2 and GLP1 receptor in normal pancreatic β-cells.

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• Insulinoma is associated with transient hyperglycemia post-surgery.
• The impact of insulinoma on normal pancreatic beta-cells remains unclear.
• Understanding beta-cell function in insulinoma is crucial for metabolic health.

Purpose of the Study:

• To investigate the expression of glucose transporter 2 (GLUT2) and glucagon-like peptide 1 receptor (GLP1R) in normal beta-cells of insulinoma patients.
• To explore the in vitro effects of high insulin concentrations on GLUT2 and GLP1R expression in beta-cells.

Main Methods:

• Comparative analysis of GLUT2 and GLP1R expression in non-tumorous islets from insulinoma patients and normal glucose tolerance (NGT) controls.
• Quantitative real-time PCR (q-PCR) and Western blotting to assess gene and protein expression.
• In vitro experiments exposing MIN6 beta-cells to high insulin concentrations.

Main Results:

• Significantly lower expression rates of GLUT2 and GLP1R were observed in non-tumorous islets of insulinoma patients compared to NGT controls.
• In vitro, high insulin exposure led to decreased GLUT2 protein levels after 12 hours and GLP1R protein levels after 24 hours.
• No significant changes in GLUT2 and GLP1R mRNA levels were detected in response to high insulin concentrations.

Conclusions:

• Insulinoma is associated with the downregulation of GLUT2 and GLP1R expression in adjacent normal pancreatic beta-cells.
• Elevated insulin levels, characteristic of insulinoma, may be responsible for this observed downregulation.
• These findings highlight a potential mechanism for altered beta-cell function in the presence of insulinoma.